Menu
Back to User profile » Dr Tianshui Niu
Papers published by Dr Tianshui Niu:
Prevalent Dominant Acinetobacter baumannii ST191/195/208 Strains in Bloodstream Infections Have High Drug Resistance and Mortality
Niu T, Guo L, Kong X, He F, Ru C, Xiao Y
Infection and Drug Resistance 2023, 16:2417-2427
Published Date: 24 April 2023
In vitro reduction of colistin susceptibility and comparative genomics reveals multiple differences between MCR-positive and MCR-negative colistin-resistant Escherichia coli
Luo Q, Niu T, Wang Y, Yin J, Wan F, Yao M, Lu H, Xiao Y, Li L
Infection and Drug Resistance 2019, 12:1665-1674
Published Date: 12 June 2019
Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
Niu T, Xiao TT, Guo L, Yu W, Chen Y, Zheng B, Huang C, Yu X, Xiao Y
Infection and Drug Resistance 2018, 11:2021-2030
Published Date: 26 October 2018
In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae
Yu W, Luo Q, Shi Q, Huang C, Yu X, Niu T, Zhou K, Zhang J, Xiao Y
Infection and Drug Resistance 2018, 11:577-585
Published Date: 24 April 2018
A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infections: tigecycline significantly increases the mortality
Xiao T, Yu W, Niu T, Huang C, Xiao Y
Infection and Drug Resistance 2018, 11:595-606
Published Date: 24 April 2018
Antibacterial effect evaluation of moxalactam against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae with in vitro pharmacokinetics/pharmacodynamics simulation
Huang C, Zheng B, Yu W, Niu T, Xiao T, Zhang J, Xiao Y
Infection and Drug Resistance 2018, 11:103-112
Published Date: 15 January 2018